Patexia Logo
Patexia Logo
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
  • All Products
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
  • All Services
IP Community
  • IP Community
  • IP Webinars
  • In the News
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Login
JoinBook a Meeting
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
Resources
  • IP Community
  • IP Webinars
  • In the News
  • Help Center
Contact
  • (310) 909-7611
  • 100 Wilshire Blvd. Suite 700
    Santa Monica, CA 90401 USA
  • info@patexia.com
  • Contact Us
Follow Us
© 2025
100 Wilshire Blvd, Suite 700, Santa Monica, CA 90401 USA
Terms and Conditions|Privacy Policy
Back to All Articles
Browse articles with tag: EU
You must be logged in to create a new article
All Articles
Knobbe Martens
5 days ago
•
PTAB Litigation
Limits of Inherent Anticipation in Product-By-Process Claims
Written by:Kenneth O. Aruda, Ph.D. and Nathan D. Reeves RESTEM, LLC v. JADI CELL, LLC Before Moore, Schall, and Taranto.... Read More
Knobbe Martens
5 days ago
•
PTAB Litigation
Jepson Claim Preamble Requires Written Description Support for Conventional Aspects of the Invention
Written by:Isabella C. Pestana and Justin J. Gillett IN RE: XENCOR, INC. Before Hughes, Stark, and Schroeder (sitting by designation). ... Read More
Knobbe Martens
Mar 13, 2025
•
Patent Litigation
District Court Finds the FDA Reasonably De-listed Eli Lilly’s Weight Loss Drug From Drug Shortage List
Written by: Rhett D. Ramsey and Robert J. Hilton, Ph.D. Congress authorized the FDA to determine whether a drug is “in... Read More
Knobbe Martens
Feb 4, 2025
Renewed Efforts in Congress for Pharmaceutical Patent Reform
Written by:Bailey R. Arenberg & Jason J. Jardine With the recent convocation of the 119th Congress, a change in administration,... Read More
Knobbe Martens
Jan 15, 2025
•
Patent Litigation
A Patent Must Describe What Is Claimed, Not What Infringes
Written by: Raymond S. Lu and Douglas B. Wentzel NOVARTIS PHARMACEUTICALS CORPORATION v. TORRENT PHARMA INC. Before Lourie, Prost, and Reyna.  Appeal... Read More
Mikele Bicolli
Jan 13, 2025
•
Featured
ANDA Litigation
Intra-Cellular Therapies Surges 15% Following Settlement of Caplyta ANDA Litigation with Sandoz
Shares of Intra-Cellular Therapies (NASDAQ: ITCI) increased by nearly 15% last week after the company reached a significant settlement with... Read More
  • <
  • 1
  • 2
  • ...
  • 60
  • >